694 NC410 is a novel immunomedicine for the treatment of solid tumors
Main Authors: | Linde Meyaard, Stefan Willems, M Ines Pascoal Ramos, Emma de Ruiter, Ana Paucarmayta, Eline Elshof, Chang Song, Zachary Cusumano, Jason Bosiacki |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction
by: M Ines Pascoal Ramos, et al.
Published: (2021-06-01) -
Collagen Fragments Produced in Cancer Mediate T Cell Suppression Through Leukocyte-Associated Immunoglobulin-Like Receptor 1
by: Saskia V. Vijver, et al.
Published: (2021-10-01) -
CT694 and pgp3 as serological tools for monitoring trachoma programs.
by: E Brook Goodhew, et al.
Published: (2012-01-01) -
NC rough cut for solid models
by: 瞿志行
Published: (1992) -
The Breakup Cross Section of the D+D Reaction at 6.94 MeV
by: Richard A.L., et al.
Published: (2016-01-01)